What's breaking now, across thousands of outlets.
(RTTNews) - Shares of uniQure N.V. (QURE) are falling about 37 percent on Tuesday morning after the company announced additional data from the ongoing Phase I/II studies of ifezuntirgene inilparvovec for the treatment of Huntington's disease.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Theo Baker, Author of "How to Rule the World: An Education in Power at Stanford University" discusses the investigative reporting behind his book about misconduct allegations tied to then-Stanford…
One of the "other" Coke stocks, Coca-Cola Europacific Partners, may be an underappreciated dividend name.
Netflix investors are too worried about the U.S. and are overlooking gains abroad, Deutsche Bank argues.
UnitedHealth is showing signs of improvement after higher medical costs pressured earnings and margins, and Kevin Simpson is starting to buy the stock again.
Key PointsThe retail behemoth turned in another strong quarter, led by its growing digital sales.
Bitcoin is up 7.33% in September, edging past 2024 as the best September on record, with one day left before the monthly candle closes.
